Impact of the use of azole fungicides, other than as human medicines, on the development of azole‐resistant Aspergillus spp.
Abstract The use of azoles in the European Union and European Economic Area (EU/EEA) other than as human medicines has raised concerns about emergence and spread of azole‐resistant Aspergillus species. EU agencies, with the support of JRC, reviewed the evidence and provided conclusions and recommend...
Saved in:
Main Authors: | European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC), European Chemicals Agency (ECHA), European Environment Agency (EEA), European Medicines Agency (EMA), European Commission's Joint Research Centre (JRC) |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | https://doi.org/10.2903/j.efsa.2025.9200 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Avian influenza overview September–December 2024
by: European Food Safety Authority, European Centre for Disease Prevention and Control, et al.
Published: (2025-01-01) -
Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents
by: Luís M. T. Frija, et al.
Published: (2023-11-01) -
Pyrvinium Pamoate Synergizes with Azoles in vitro and in vivo to Exert Antifungal Efficacy Against Candida auris and Other Candida Species
by: Zhang J, et al.
Published: (2025-02-01) -
Erratum: State of the literature discussing smoke-free policies globally:
A narrative review
by: European Publishing Production Team
Published: (2024-01-01) -
Azole Resistance and <i>ERG11</i> Mutation in Clinical Isolates of <i>Candida tropicalis</i>
by: Adriele Celine Siqueira, et al.
Published: (2025-01-01)